**Question:** Which of the following group of drugs should be avoided in diabetics?

**Core Concept:** Diabetes management involves proper medication choices that minimize complications and adverse effects on the diabetic patient. Certain medications can exacerbate hyperglycemia or have detrimental effects on the diabetic patient.

**Why the Correct Answer is Right:**

*Option A:* Salbutamol (SALB) belongs to the beta-agonist class of drugs, which can lead to increased blood glucose levels due to its stimulation of beta receptors, particularly in the liver. In diabetics, SALB may cause hyperglycemia or worsen glycemic control.

*Option B:* Metoclopramide (MET) is a dopamine antagonist used for its gastrokinetic properties. However, in diabetic patients, MET can cause postural hypoglycemia (low blood sugar) due to its effect on dopamine receptors in the hypothalamus, leading to increased pancreatic insulin secretion.

*Option C:* Sertraline (SERT) is a selective serotonin reuptake inhibitor (SSRI) used for depression and anxiety. In diabetics, SERT can cause weight gain, which is a significant concern as obesity increases the risk of developing type 2 diabetes and worsens glycemic control in type 1 and type 2 diabetics.

*Option D:* Aceclofenac (ACE) is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation management. In diabetics, ACE inhibitors are known to increase the risk of hyperkalemia (high potassium levels) due to their effect on the renin-angiotensin-aldosterone system.

**Why Each Wrong Option is Incorrect:**

*Option A (SALB):* Beta-agonists, like SALB, are generally contraindicated in diabetics due to their potential to cause hyperglycemia and worsen glycemic control.

*Option C (SERT):* Weight gain is a known side effect of SSRIs like SERT, which poses a risk for developing type 2 diabetes and worsens glycemic control in those with existing type 1 or type 2 diabetes.

*Option D (ACE):* ACE inhibitors, such as ACE, have the potential to increase the risk of hyperkalemia due to their effect on the renin-angiotensin-aldosterone system.

**Core Concept:** When prescribing medications to diabetic patients, it is essential to consider potential adverse effects on glycemic control, weight, electrolyte imbalances, and overall cardiovascular risk. Choosing appropriate medications can improve patient outcomes and minimize complications.